HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Pierre Benoit Selected Research

ferrociphenol

2/2012Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
12/2011Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
1/2010Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.
9/2008Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Pierre Benoit Research Topics

Disease

32Neoplasms (Cancer)
07/2020 - 05/2002
22Glioma (Gliomas)
06/2019 - 05/2002
7Glioblastoma (Glioblastoma Multiforme)
02/2020 - 04/2010
7Melanoma (Melanoma, Malignant)
02/2020 - 02/2012
4Brain Neoplasms (Brain Tumor)
11/2014 - 01/2004
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2012 - 03/2004
4Parkinson Disease (Parkinson's Disease)
04/2007 - 06/2002
3Neoplasm Metastasis (Metastasis)
07/2020 - 11/2014
2Inflammation (Inflammations)
02/2021 - 01/2017
2Infections
03/2019 - 11/2012
2Gliosarcoma
02/2012 - 12/2011
2Traumatic Brain Injuries (Traumatic Brain Injury)
06/2009 - 07/2006
2Hepatocellular Carcinoma (Hepatoma)
06/2005 - 10/2004
2Heart Diseases (Heart Disease)
11/2002 - 07/2002
1Low Back Pain (Lumbago)
08/2022
1Intervertebral Disc Degeneration
08/2022
1Foreign-Body Reaction
07/2021
1Eye Diseases (Eye Disease)
02/2021
1Ovarian Neoplasms (Ovarian Cancer)
07/2020
1Flushing
07/2020
1Cysts
03/2019
1Lung Neoplasms (Lung Cancer)
01/2019
1Intellectual Disability (Idiocy)
01/2019
1Communicable Diseases (Infectious Diseases)
11/2017
1Alopecia (Baldness)
11/2017
1Fibrosis (Cirrhosis)
01/2017
1Lymphoma (Lymphomas)
01/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2015
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
07/2015
1Carcinogenesis
11/2014
1Cardiotoxicity
11/2013
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2013
1Carcinoma (Carcinomatosis)
10/2013

Drug/Important Bio-Agent (IBA)

28NanocapsulesIBA
08/2022 - 12/2007
28LipidsIBA
08/2022 - 07/2004
9Small Interfering RNA (siRNA)IBA
08/2019 - 01/2011
8Fluorouracil (Carac)FDA LinkGeneric
06/2019 - 05/2002
7Proteins (Proteins, Gene)FDA Link
01/2017 - 03/2004
6Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 12/2007
5GemcitabineFDA Link
02/2020 - 02/2013
4SolutionsIBA
10/2018 - 06/2003
4ferrociphenolIBA
02/2012 - 09/2008
4Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
11/2005 - 06/2002
3SuspensionsIBA
03/2019 - 01/2004
3DNA (Deoxyribonucleic Acid)IBA
12/2012 - 03/2011
3poly(methylidene malonate) 2.1.2IBA
10/2006 - 06/2003
3EmulsionsIBA
06/2005 - 05/2002
2MicellesIBA
11/2017 - 09/2008
2Fluorescent Dyes (Fluorescent Probes)IBA
01/2016 - 04/2013
2ProdrugsIBA
07/2015 - 02/2012
2ErbB Receptors (EGF Receptor)IBA
03/2015 - 01/2014
2Temozolomide (Temodar)FDA LinkGeneric
03/2015 - 01/2014
2ChitosanIBA
03/2015 - 01/2014
2Peptides (Polypeptides)IBA
05/2014 - 04/2013
2Drug CarriersIBA
04/2013 - 09/2008
2Antineoplastic Agents (Antineoplastics)IBA
02/2013 - 03/2004
2Ganciclovir (Cytovene)FDA LinkGeneric
12/2012 - 02/2012
2Transferrin (beta 2 Transferrin)IBA
06/2012 - 01/2011
2PolymersIBA
11/2011 - 10/2006
2Etoposide (VP 16)FDA LinkGeneric
12/2007 - 05/2006
2Polylactic Acid-Polyglycolic Acid CopolymerIBA
11/2005 - 01/2004
2Nerve Growth Factors (Neurotrophins)IBA
03/2005 - 02/2004
2Amiodarone (Amiodarona)FDA LinkGeneric
11/2002 - 07/2002
1MicroRNAs (MicroRNA)IBA
08/2022
1Dichlorodiphenyldichloroethane (DDD)IBA
08/2022
1HydrogelsIBA
07/2021
1Cisplatin (Platino)FDA LinkGeneric
07/2020
1polyarginineIBA
07/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2020
1Hyaluronic Acid (Hyaluronan)IBA
07/2020
11,2-distearoylphosphatidylethanolamine (DSPE)IBA
08/2019
1creatine transporterIBA
01/2019
1protoporphyrin IXIBA
01/2019
1AcidsIBA
01/2019
1Docetaxel (Taxotere)FDA Link
01/2019
1CurcuminIBA
10/2018
1ferrocifenIBA
12/2017
1MetalsIBA
12/2017
1Antidepressive Agents (Antidepressants)IBA
11/2017
1Liposomes (Liposome)IBA
11/2017
1FullerenesIBA
11/2017
1Dendrimers (Dendrons)IBA
11/2017
1CPG-oligonucleotideIBA
11/2015
1Galectin 1 (LGALS1)IBA
03/2015
1IntegrinsIBA
05/2014
1Prostaglandins AIBA
05/2014
1Endothelial Growth FactorsIBA
10/2013
1Cell-Penetrating PeptidesIBA
04/2013
1NFL-TBS.40-63 peptideIBA
04/2013

Therapy/Procedure

14Therapeutics
08/2022 - 09/2011
13Microspheres (Microsphere)
11/2006 - 05/2002
9Drug Therapy (Chemotherapy)
07/2020 - 06/2003
7Radiotherapy
03/2015 - 09/2004
4Intravenous Injections
11/2014 - 03/2011
3Cell- and Tissue-Based Therapy (Cell Therapy)
01/2012 - 03/2005
2Intravenous Administration
10/2018 - 07/2004
1Cytoreduction Surgical Procedures
07/2020
1Anesthesia
11/2017
1Immunotherapy
01/2016
1Subcutaneous Injections
07/2015